These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1029989)

  • 41. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
    González-Gómez A; García-Barreto D; Cabrera R; Toruncha A; Hernández-Cañero A
    Pharmacology; 1982; 25(1):33-8. PubMed ID: 6289362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol.
    Fagard R; Amery A; Deplaen JF; Lijnen P; Missotten A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():215s-217s. PubMed ID: 799551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of low-dose atenolol on postural and postprandial changes in heart rate, blood pressure, venous plasma catecholamines, and plasma renin activity.
    de Mey C; Hansen-Schmidt S; Enterling D; Meineke I
    Eur J Clin Pharmacol; 1989; 37(2):121-5. PubMed ID: 2676558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.
    Struthers AD; Reid JL; Whitesmith R; Rodger JC
    Clin Sci (Lond); 1983 Aug; 65(2):143-7. PubMed ID: 6861446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J; Pozet N; McAinsh J; Legheand J; Zech P
    Eur J Clin Pharmacol; 1977 Nov; 12(3):175-80. PubMed ID: 590303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased plasma vasopressin in low renin essential hypertension.
    Os I; Kjeldsen SE; Skjøtø J; Westheim A; Lande K; Aakesson I; Frederichsen P; Leren P; Hjermann I; Eide IK
    Hypertension; 1986 Jun; 8(6):506-13. PubMed ID: 2872161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.
    Hansson BG; Hökfelt
    Eur J Clin Pharmacol; 1976 Feb; 9(4):245-51. PubMed ID: 9301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Postgrad Med J; 1977; 53 Suppl 3():99-101. PubMed ID: 928275
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma noradrenaline and adrenaline and beta-adrenoreceptor responsiveness in renin subgroups of essential hypertension.
    Bühler FR; Bertel O; Kiowski DW
    Clin Sci Mol Med Suppl; 1978 Dec; 4():57s-60s. PubMed ID: 215376
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
    Aström H; Vallin H
    Postgrad Med J; 1977; 53 Suppl 3():84. PubMed ID: 928272
    [No Abstract]   [Full Text] [Related]  

  • 52. Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.
    Waal-Manning HJ; Bolli P
    Br J Clin Pharmacol; 1980 Jun; 9(6):553-60. PubMed ID: 6992822
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of atenolol on the excretion of catecholamines and their metabolites and dihydroxyphenylalanine (DOPA) in patients with essential hypertension].
    Wocial B; Januszewicz W; Sznajderman M; Feltynowski T
    Pol Arch Med Wewn; 1982 Mar; 67(3):87-91. PubMed ID: 6810328
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term hypotensive effect of atenolol 4% eyedrops.
    Brenkman RF
    Br J Ophthalmol; 1978 May; 62(5):287-91. PubMed ID: 656355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic effects of bunitrolol and pindolol on blood pressure, heart rate, vascular lesions, and plasma renin activity in hypertensive rats.
    Hasegawa Y; Watanabe TX; Kawashima K; Sokabe H; Saito K
    Jpn J Pharmacol; 1982 Aug; 32(4):742-5. PubMed ID: 6127427
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of atenolol on the discharge of sympathetic efferent nerves in the anaesthetised cat [proceedings].
    Scott EM; Conway J
    Br J Pharmacol; 1978 Nov; 64(3):394P. PubMed ID: 719253
    [No Abstract]   [Full Text] [Related]  

  • 57. The duration of action of atenolol in man [proceedings].
    Harry JD; Young J
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P-388P. PubMed ID: 901711
    [No Abstract]   [Full Text] [Related]  

  • 58. [Atenolol. Successful therapy of light forms of coronary disease using a beta blockader].
    Degenring FH; Degenering FW
    ZFA (Stuttgart); 1978 Feb; 54(4):237-42. PubMed ID: 414471
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction of atenolol and adrenaline with respect to intraocular pressure.
    Rushton A
    Br J Clin Pharmacol; 1979 Jun; 7(6):575-8. PubMed ID: 465279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
    Kjeldsen SE; Eide I; Aakesson I; Amundsen R; Eriksen IL; Leren P
    Acta Med Scand; 1983; 214(5):367-71. PubMed ID: 6660046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.